Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Rupafin (GSK)
- INDICATIONS: Allergic rhinitis and chronic idiopathic urticaria
- CLASS: Histamine H1 receptor antagonist
- HALF-LIFE: 5.9 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Alcohol, CNS depressants, Erythromycin, Grapefruit Juice, Ketoconazole, statins
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of rupatadine in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 08/07/2024
